[go: up one dir, main page]

GB9827500D0 - Compounds for control of eating, growth and body weight - Google Patents

Compounds for control of eating, growth and body weight

Info

Publication number
GB9827500D0
GB9827500D0 GBGB9827500.1A GB9827500A GB9827500D0 GB 9827500 D0 GB9827500 D0 GB 9827500D0 GB 9827500 A GB9827500 A GB 9827500A GB 9827500 D0 GB9827500 D0 GB 9827500D0
Authority
GB
United Kingdom
Prior art keywords
eating
growth
compounds
control
body weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9827500.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WaPharm AB
Original Assignee
WaPharm AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WaPharm AB filed Critical WaPharm AB
Priority to GBGB9827500.1A priority Critical patent/GB9827500D0/en
Publication of GB9827500D0 publication Critical patent/GB9827500D0/en
Priority to PCT/GB1999/004254 priority patent/WO2000035952A2/en
Priority to AU17899/00A priority patent/AU1789900A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9827500.1A 1998-12-14 1998-12-14 Compounds for control of eating, growth and body weight Ceased GB9827500D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9827500.1A GB9827500D0 (en) 1998-12-14 1998-12-14 Compounds for control of eating, growth and body weight
PCT/GB1999/004254 WO2000035952A2 (en) 1998-12-14 1999-12-14 Compounds for control of eating, growth and body weight
AU17899/00A AU1789900A (en) 1998-12-14 1999-12-14 Compounds for control of eating, growth and body weight

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827500.1A GB9827500D0 (en) 1998-12-14 1998-12-14 Compounds for control of eating, growth and body weight

Publications (1)

Publication Number Publication Date
GB9827500D0 true GB9827500D0 (en) 1999-02-10

Family

ID=10844193

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9827500.1A Ceased GB9827500D0 (en) 1998-12-14 1998-12-14 Compounds for control of eating, growth and body weight

Country Status (3)

Country Link
AU (1) AU1789900A (en)
GB (1) GB9827500D0 (en)
WO (1) WO2000035952A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716810B1 (en) 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
IL145406A0 (en) 1999-03-29 2002-06-30 Procter & Gamble Melanocortin receptor ligands
JP2003534240A (en) 2000-01-18 2003-11-18 メルク エンド カムパニー インコーポレーテッド Cyclic peptides that are potent selective melanocortin-4 receptor antagonists
GB0019357D0 (en) 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines
GB0019359D0 (en) 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel guanidines
US7342089B2 (en) * 2001-07-11 2008-03-11 Palatin Technologies, Inc. Cyclic peptides for treatment for cachexia
AU2002322466B2 (en) * 2001-07-11 2007-08-30 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
JP2005504043A (en) 2001-08-10 2005-02-10 パラチン テクノロジーズ インク． Peptidomimetics of biologically active metal peptides
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
JP2006527773A (en) * 2003-06-19 2006-12-07 イーライ リリー アンド カンパニー Melanocortin receptor 4 (MC4) agonist and its use
ES2397241T3 (en) 2004-01-21 2013-03-05 Novo Nordisk Health Care Ag Conjugation of peptides by transglutaminase
DE102007020152A1 (en) * 2007-04-26 2008-10-30 Charité - Universitätsmedizin Berlin Agent for anti-infective treatment of a patient
AU2009257631B2 (en) 2008-06-09 2014-07-24 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
AU2010259008C1 (en) 2009-06-08 2016-04-21 Palatin Technologies, Inc. Melanocortin receptor-specific peptides
UY32690A (en) 2009-06-08 2011-01-31 Astrazeneca Ab SPECIFIC PEPTIDES FOR MELANOCORTIN RECEPTORS
EP2440572B1 (en) 2009-06-08 2017-04-05 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
CA2781405A1 (en) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Melanocortin-1 receptor-specific linear peptides
CA2781402C (en) 2009-11-23 2017-03-21 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
EP3450449A3 (en) 2013-03-15 2019-06-12 Rhythm Pharmaceuticals, Inc. Peptide compositions
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
SE9700620D0 (en) * 1997-02-21 1997-02-21 Wapharm Ab Cyclic peptides with selectivity for MSH receptor subtypes

Also Published As

Publication number Publication date
WO2000035952A2 (en) 2000-06-22
AU1789900A (en) 2000-07-03
WO2000035952A3 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
GB9827500D0 (en) Compounds for control of eating, growth and body weight
AU1746600A (en) Reduction, elimination, or stimulation of hair growth
HUP0001993A3 (en) Fungicidal trifluoromethylalkylamino-triazolo [1,5a] pyrimidine derivatives, preparation and use thereof
HUP0100817A3 (en) 2-pyridylmethylamine derivatives useful as fungicides, their use, intermediates and preparation thereof
ZA986822B (en) Reduction of hair growth
GB9916202D0 (en) Crystalline trehalose dihydrate,its preparation and uses
EP1054900A4 (en) Therapeutic uses of keratinocyte growth factor-2
MXPA01005818A (en) Composition and method for regulation of body weight and associated conditions.
GB2341811B (en) Control of weight during evaporation of samples
AU7755398A (en) Method for reducing body weight
AU5671099A (en) Compounds having growth hormone releasing activity
AUPQ044499A0 (en) Control of wool growth
GB9814604D0 (en) Treatment of foodstuffs
EG22587A (en) Novel imidamide derivatives and their use for controlling animal pests
GB9802151D0 (en) Eating implement
GB2338709B (en) 2,5-dimercapto-1,3,4-thiadiazole dilithium salt and its dihydrate and their manufacture
AUPP582198A0 (en) Modified human growth hormone
GB0313584D0 (en) 2,5-Dimercapto-1,3,4-Thiadiazole dilithium salt and its dihydrate and their manufacture
AU3632099A (en) Biologically active 2-r-5-amino-1,3,4-thiadiazole derivatives
AUPP531598A0 (en) Modular fishing rod and carrier
AU6069799A (en) Modified human growth hormone
AU133856S (en) Lure body
AU2003236478A1 (en) Therapeutic Uses of Keratinocyte Growth Factor-2
ZA9710380B (en) Process for controlling body weight
AU6564100A (en) Wagon for the preparation and distribution of animal foodstuff

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)